Lek among the Top 10 Slovenian employers 2007
Lek, a Sandoz company, was ranked among the top 10 employers in Slovenia that were announced at a ceremony organized on 21 November 2007 by the company Moje delo (My Job) within the scope of the job fair Career/07. The most distinguished employers were chosen on the basis of a survey about the reputation of the employers, which included 285 Slovenian companies.
The survey was carried out for nine months to identify the best employer to work for and included almost 9.000 candidates from the active population in Slovenia.
The top 10 certificates were awarded to the companies which significantly exceeded the so called threshold of reputation and were ranked as the best and most desirable employers by the candidates on the job market. Other companies that received the certificates besides Lek were Adria Airways, IMB Slovenia, Microsoft, Kompas, Telekom and others. The title of the most distinguished employer was granted to Krka this year.
Lek’s employees are offered interesting opportunities for permanent education, personal growth and career development. As part of a global corporation, Lek also provides opportunities for working abroad in groups of top experts from different fields, as well as cooperation in important international projects. The fact that we are the only company in Slovenia who has already entered the biopharmaceuticals field is also one of the important motivations to seek work in Lek.
We put the concern for safety, health and wellness first and carry out various internal projects to ensure a safe working environment for all employees while encouraging responsible behaviour, both at work and at home.
This year Lek was among the first companies in Slovenia to receive the Family-Friendly Company certificate. As part of the Family-Friendly Company campaign we introduced some new activities which further contributed to balancing of work and personal life, especially for young mothers and families. Among other measures we will introduce a possibility for later arrival in the office for associates with small children, working from home (where working process alows it); we introduced family services and provided day care for the children of employees during the school holidays, help for family members etc. In the following months we are also opening a new building to accommodate the kindergarten which has operated on the site of Lek Ljubljana for many years.
Lek has been putting a lot of effort into establishing a friendly working environment for all employees for as long as six decades and will remain committed to it also in the future.
Lek, član skupine Sandoz, je eden od stebrov vodilne globalne
generične družbe Sandoz. Deluje kot globalni razvojni center za izdelke in
tehnologije, kot globalni proizvodni center za učinkovine in zdravila, kot
kompetenčni center za razvoj vertikalno integriranih izdelkov, kot kompetenčni
center Sandoza na področju razvoja in proizvodnje biofarmacevtskih izdelkov in
kot center oskrbe za trge SVE, JVE in SND, prodaje Slovenije ter prodajnih
storitev za globalne Sandozove trge. Lek podpira delovanje Sandoza na njegovi
poti postati prva generična farmacevtska družba na svetu. Lekovo srednje- in
dolgoročno poslovanje sledi viziji in strategiji Sandoza postati vodilni
svetovni generični proizvajalec. Lek zaposluje približno 2820 ljudi in je v letu
2006 dosegel prodajo v višini 904 milijonov USD. Podrobnejše informacije so na
voljo na http://www.lek.si.
Sandoz, divizija skupine Novartis, je vodilna družba na svetu na
področju generičnih zdravil in ponuja široko paleto visoko kakovostnih, cenovno
dostopnih zdravil, ki niso več zaščitena s patenti. Sandoz ima v svojem
portfelju več kot 840 učinkovin v več kot 5000 oblikah po vsem svetu. Med
njegove ključne skupine zdravil sodijo antibiotiki, zdravila za bolezni in
motnje osrednjega živčevja ter zdravila za prebavila, srce in ožilje in različne
hormonske terapije. Sandoz razvija, izdeluje in trži ta zdravila, pa tudi
posamezne farmacevtske in biotehnološke učinkovine in antiinfektive. Poleg močne
organske rasti v zadnjih letih pa je Sandoz opravil tudi vrsto združitev,
vključno z družbami Lek (Slovenija), Sabex (Kanada), Hexal (Nemčija) in Eon Labs
(ZDA), in zdaj prodaja svoja zdravila v več kot 110 državah. V letu 2006 je imel
Sandoz okoli 21.000 zaposlenih po vsem svetu in je dosegel prodajo v višini 6
milijard USD.
Novartis AG (NYSE: NVS) je vodilna družba na svetu, ki izdeluje
zdravila za varovanje zdravja, zdravljenje bolezni in izboljšanje počutja. Naš
cilj je iznajti, razviti in uspešno prodajati inovativna zdravila za zdravljenje
bolnikov, lajšanje njihovega trpljenja in povečanje kakovosti njihovega
življenja. Novartis je edina družba, ki ima vodilni položaj tako pri
patentiranih zdravilih kot generikih. Ves čas krepimo svoj portfelj zdravil, ki
temelji na strateških osnovah rasti na področju inovativnih zdravil, visoko
kakovost in cenovno ugodnejše generike ter vodilne blagovne znamke zdravil brez
recepta, ki se uporabljajo za samozdravljenje. V letu 2006 so družbe v tej
skupini dosegle neto prodajo v višini 37 milijard USD in neto dobiček v višini
7,2 milijarde USD. Približno 5,4 milijarde USD je bilo vloženih v raziskave in
razvoj. Skupina Novartis ima sedež v Baslu v Švici, v njenih članicah, ki
poslujejo v več kot 140 državah po vsem svetu, pa je zaposlenih približno
101.000 ljudi. Za dodatne informacije obiščite našo spletno stran:
http://www.novartis.com.
V sporočilu za javnost so izjave in napovedi o Lekovem poslovanju v prihodnje. Napovedi obsegajo ocene, oblikovane na podlagi vseh informacij, ki jih imamo trenutno na voljo. Če bi se izkazalo, da so predvidevanja teh napovedi nezanesljiva, bi bili lahko dejanski rezultati poslovanja drugačni od pričakovanih.
Za dodatne informacije se, prosim, obrnite na:
Katarino Klemenc Dinjaški
Korporativno komuniciranje
Lek farmacevtska družba d. d.
telefon: 01 580 22 43
telefaks: 01 580 24 32
komuniciranje.lek@sandoz.com
